BioFreedom QCA Study in CAD Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 200 participants.

Also called NCT03307213

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03307213
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark, Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03307213. Randomized; single masking; primary purpose treatment. Start 2018-06-19 (actual); primary completion 2019-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BioFreedom QCA Study in CAD Patients
Acronym
BioFreedomQCA
Condition
Cardiac Death
Intervention (Device)
BioFreedom™ CoCr Biolimus A9™ stent
Intervention (Device)
BioFreedom™ SS Biolimus A9™ stent
Lead sponsor
Biosensors Europe SA (class: industry)

Record details

Record id
cardio:ct-nct03307213
Content hash
9c8d59d57178ddc38758468a92d3dffc3b34f344ecf245ea4711a0526d97057c